EARLY ASSESSMENT OF MOTOR RECOVERY IN SPINAL CORD INJURY PATIENTS

摘要

Prognosis of an acute neuropathy (myelopathy) can be made by assessing the levels of markers taken from body fluid or tissues samples of patients at an early stage from diagnosis. This is applicable in particular to spinal cord injury (SCI) where bone resorption markers are demonstrated to provide bimodality. The bimodality is particularly apparent where ratios of bone resorption markers measured in early stage injury can be aligned with later conducted ASIA score AB and CD loss of function assessments.